Utama › Gangguan Depresi Major › New York
Kajian klinikal Gangguan Depresi Major di New York
48 kajian untuk Gangguan Depresi Major sedang mencari peserta di lokasi di New York.
Bandar di New York
Teks kajian rasmi (Bahasa Inggeris)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Adams Clinical Bronx, The Bronx
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Integrative Clinical Trials LLC, Brooklyn
- SPRI Clinical Trials, LLC, Brooklyn
- Bioscience Research LLC, Mount Kisco
- dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 74 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Integrative Clinical Trials LLC, Brooklyn
- SPRI Clinical Trials, LLC, Brooklyn
- Bioscience Research LLC, Mount Kisco
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 74 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Ima Clinical Research - Nyc Midtown, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07621237Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- SPRI Clinical Trials, LLC, Brooklyn
- Manhattan Behavioral Medicine, New York
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Harlem, New York
- New York State Psychiatric Institute, New York
- Davis Clinical (Adams Clinical Bronx), The Bronx
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, New York
- Vanda Investigational Site, New York
- Vanda Investigational Site, Staten Island
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06830044DBS for TRD With the Medtronic Percept PC
- Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York
Mengambil peserta
Umur 25 hingga 70 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT05773755Pattern Separation in Major Depressive Disorder
- New York State Psychiatric Institute (NYSPI), New York
Mengambil pesertaFasa 1
Umur 18 hingga 50 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07139834A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Brooklyn
- Seaport Investigator Site, Cedarhurst
- Seaport Investigator Site, New York
- dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Integrative Clinical Trials LLC, Brooklyn
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07284667A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Bioscience Research, LLC, Mount Kisco
- Fieve Clinical Research, Inc., New York
- IMA Clinical Research, New York
Mengambil pesertaFasa 3
Umur 18 hingga 74 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, New York
- Draig Clinical Site, New York
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Mount Sinai Hospital, New York
Mengambil peserta
Umur 22 hingga 70 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, New York
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT07300969NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, New York
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT06911112A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Adams Clinical Harlem, New York
Mengambil pesertaFasa 3
Umur 18 hingga 74 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT07592689NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06963021A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Adams Clinical Harlem, New York
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Integrative Clinical Trials, Brooklyn
- Richmond Behavioral Associates, Staten Island
Mengambil pesertaFasa 3
Umur 18 hingga 74 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Neurobehavioral Research, Inc., Cedarhurst
Mengambil pesertaFasa 2
Umur 18 hingga 64 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Neurobehavioral Research, Inc, Cedarhurst
- IMA Clinical Research - NYC Midtown, New York
- IMA Clinical Research - NYC Uptown, New York
Mengambil pesertaFasa 2
Umur 18 hingga 64 · Semua jantina · Dikemas kini 27 Jul 2026 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Glen Oaks
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jul 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, Mount Kisco
- Neurocrine Clinical Site, New York
- dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jul 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Brooklyn
- Clinical Research Site, New York
- Clinical Research Site, New York
- dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 24 Jul 2026 · NCT07484217Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
- NYU Langone Health, New York
Mengambil peserta
Umur 24 hingga 65 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT07111390A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Ima Clinical Research - Manhattan /ID# 278212, New York
- Manhattan Behavioral Medicine /ID# 277910, New York
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 15 Jun 2026 · NCT07276997tDCS: Sleep to Mood in Depression (S2M-D)
- NYU Langone Health, New York
Mengambil peserta
Umur 18 hingga 65 · Semua jantina · Dikemas kini 8 Jun 2026 · NCT07572526Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Harlem, New York
- Adams Clinical, Bronx, The Bronx
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mei 2026 · NCT05800925A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- The Medical Research Network, LLC, New York
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 11 Mei 2026 · NCT06524830Aβ Dynamics in LLMD
- NYU Langone Health, New York
- Nathan S. Kline Institute for Psychiatric Research, Orangeburg
Mengambil pesertaFasa 4
Umur 60 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT05004987Mindfulness-Based fMRI Neurofeedback for Depression
- Columbia University Irving Medical Center, New York
Mengambil peserta
Umur 13 hingga 18 · Semua jantina · Dikemas kini 29 Apr 2026 · NCT05617495Neutralizing Interleukin (IL)-6
- Icahn School of Medicine at Mount Sinai, New York
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
Umur 18 hingga 70 · Semua jantina · Dikemas kini 29 Apr 2026 · NCT07493317Maintenance rTMS for Depression (Maitr-De)
- Weill Cornell Medicine, New York
Mengambil peserta
Umur 18 hingga 80 · Semua jantina · Dikemas kini 29 Apr 2026 · NCT06938841Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
- Weill Cornell Medicine, New York
Mengambil peserta
Umur 50 hingga 80 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT05925322Biomarker-guided rTMS for Treatment Resistant Depression
- Weill Cornell Medicine, New York
Mengambil pesertaFasa 3
Umur 22 hingga 65 · Semua jantina · Dikemas kini 25 Feb 2026 · NCT04041479The Role of mGluR5 in CBT-I
- Stony Brook University: Dept of Psychiatry, Stony Brook
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Feb 2026 · NCT07076342Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
- NYU Langone Health, New York
- Nathan Kline Institute for Psychiatric Research, Orangeburg
Mengambil peserta
Umur 18 hingga 65 · Semua jantina · Dikemas kini 5 Feb 2026 · NCT05573074Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #105, Brooklyn
- Autobahn Site #134, Brooklyn
- Autobahn Site #104, Staten Island
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 20 Jan 2026 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Mount Kisco
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Okt 2025 · NCT06786624Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.